Article

Applied Clinical Trials

Applied Clinical Trials

Applied Clinical Trials-09-01-2001
Volume

Monitoring Where Others Take Holidays

A creative mobile monitoring model could help sponsors tap the potential of southern Europe (and Mexico) as areas for clinical research.

External Link - article-15518.pdf

Articles in this issue
Connecting at the Connectathon
Patient Demands vs. Product Development
EU Proposes Authorization Changes
FDA Warning Letters
The Clinical Audit in Pharmaceutical Development
What a Form 483 Really Means

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
The Reality of Operational Flexibility for Trial Sites
The Reality of Operational Flexibility for Trial Sites
Apreo Health Launches Pivotal BREATHE-3 Trial for Severe Emphysema
Apreo Health Launches Pivotal BREATHE-3 Trial for Severe Emphysema
Future-Proofing Trial Protocols to Avoid CRLs
Future-Proofing Trial Protocols to Avoid CRLs
Related Content
Phase II Trial Data Lead to FDA Breakthrough Therapy Designation for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer
August 20th 2025

Phase II Trial Data Lead to FDA Breakthrough Therapy Designation for Ifinatamab Deruxtecan in Extensive-Stage Small Cell Lung Cancer

Don Tracy, Associate Editor
ACT Brief Episode 4: New Data on Trial Delays, Hybrid Payment Models, and Managing Complexity
August 20th 2025

ACT Brief Episode 4: New Data on Trial Delays, Hybrid Payment Models, and Managing Complexity

Andy Studna, Senior Editor
How Policy Changes Could Impact Vaccine Trials and Public Participation
August 20th 2025

How Policy Changes Could Impact Vaccine Trials and Public Participation

Don Tracy, Associate Editor
ACT Brief Episode 3: Breaking Down Data Silos to Accelerate Clinical Trials
August 20th 2025

ACT Brief Episode 3: Breaking Down Data Silos to Accelerate Clinical Trials

Andy Studna, Senior Editor
Embracing Proactive Multi-Indication Development for Metabolic Therapies
August 20th 2025

Embracing Proactive Multi-Indication Development for Metabolic Therapies

Alan Baldridge, MD
© Destina - © Destina - stock.adobe.com
August 20th 2025

Phase II B-SUPREME Trial Launches for ALG-000184 in Chronic Hepatitis B

Andy Studna, Senior Editor
© 2025 MJH Life Sciences

All rights reserved.